BriaCell Activates A Clinical Site in Florida for Phase IIa Study of its Lead Candidate in Advanced Breast Cancer
BERKELEY, Calif. and VANCOUVER, British Columbia, Apr 23, 2018 (GLOBE NEWSWIRE via COMTEX) -- BriaCell Therapeutics Corp. ("BriaCell") (BCT) (otcqb:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted …